| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |